EDITORIAL
ORIGINAL ARTICLE
Objective. To study the effect of the synthetic analog of the platelet activation factor (based on the 1-alkyl-2-alkylcarbamoyl-glycerol) on the tone of vascular smooth muscle cells and hemodynamic parameters. Design and methods. We studied the vasodilator properties of 1-O-hexadecyl-2-O-methylcarbamoylglycerol, the substance from the group of 1-alkyl-2-alkylcarbamoylglycerols. Systemic arterial pressure, stroke volume and heart rate were recorded by the Biopac hardware complex in Wistar rats 3 hours after intragastric administration of the drug. We studied (the Myobath II Tissue bath system) mechanical tension of isolated aortic segments from Wistar and SHR rats precontracted with phenylephrine and nonisosomotic solutions. Using the Wire Myograph 620M system, we recorded changes in the contractility of the small mesenteric arteries, the artery of the gastrocnemius muscle and the renal interlobar arteries of the Wistar rats precontracted with methoxamine. Results. 1-O-hexadecyl-2-O-methylcarbamoylglycerol decreased arterial pressure in Wistar rats after intragastric administration due to the decrease in specific peripheral resistance, but does not exert an evident relaxation acting on isolated vessels pre-reduced by activation of α1-adrenoreceptors with phenylephrin and methoxamine. 1-O-hexadecyl-2-O-methylcarbamoylglycerol reduced the hyper-, hypo-, and isoosmotic contraction of the aortic segments from Wistar rats, but increased (isoosmotic contraction) or did not change (hyper- and hypoosmotic contraction) it in the vessels obtained from SHR rats. Conclusions. The pressure reducing effect of 1-O-hexadecyl-2-O-methylcarbamoylglycerol is not due to direct action on vascular cells. It might involve nervous/humoral mechanisms of blood pressure regulation. However, 1-O-hexadecyl-2-O-methylcarbamoylglycerol reduces the contraction amplitude induced by incubation in the non-isoosmotic environment in normotensive rats. However, the effect is not present in hypertensive rats indicating the possible involvement of NKCC in the mechanisms of the drug substance.
Background. Hypertension (HTN) represents the most significant factor associated with the development of chronic heart failure (CHF) with preserved left ventricular ejection fraction (LVEF). Low-intensity systemic inflammation is considered an important element for the pathogenesis of both HTN and CHF. Objective. To set gender-dependent features of pro-inflammatory status in middle-aged patients with HTN complicated by non-severe CHF with preserved LVEF. Design and methods. The study involved 165 middle-aged subjects. The main study group comprised 104 patients (including 55 males) with HTN complicated by CHF with preserved LVEF. CHF diagnosis was confirmed by the elevated blood plasma N‑terminal brain natriuretic peptide precursor and 6‑minute walk test. Also, the main group was stratified depending on the presence of the 1st or the 2nd grade of left ventricular diastolic dysfunction (LVDD). The comparison group consisted of 30 patients with stage II HTN (including 15 males), and a control group — of 31 normotensive individuals (including 15 males). In all subjects we measured serum levels of C‑reactive protein (CRP), tumor necrosis factor alpha (TNF-α), interleukin‑6 (IL‑6). The data were processed by the program Statistica for Windows (version 10.0). Results. In each group the blood markers of proinflammatory status were normal. Males of the main group showed higher levels of CRP, TNF-alpha, IL‑6 than females. Hypertensive males and females with CHF with preserved LVEF demonstrated significantly higher indices of all parameters than in the comparison group. We also analyzed data depending significantly greater than in subjects with the 1st LVDD grade (both among males and females). Conclusions. In comparison with females, males with HTN complicated by CHF with preserved LVEF have significantly higher CRP, TNF-α, IL‑6 serum levels. Development of CHF with preserved LVEF in HTN patients is associated with increased intensity of the pro-inflammatory pattern among both males and females. Regardless of gender and clinical status of CHF, hypertensive patients with the 2nd grade of LVDD are characterized by higher serum levels of CRP, TNF-α, IL‑6 compared to those with the 1st grade of LVDD.
REVIEW
LECTURE
Intense emotions cause arousal of the central nervous system, sympathetic activation, blood pressure (BP) increase and hyperventilation. Continuous negative emotions coming with hyperventilation lead to increase in CO2-chemosensitivity that keeps chronic hypocapnia constant and results in BP dysregulation and stable arterial hypertension (AH). The key mechanism of a hypertensive effect of chronic hyperventilation probably lies in sensitivity changes of CO2-chemoreceptors. Respiratory training with periodic hypercapnia has potential therapeutic effect in HTN by restoring CO2-chemoreceptor sensitivity and increasing antioxidant activity. Hypocapnia violates autoregulation mechanisms. Cerebral blood vessels lose their ability to neutralize BP surges, which negatively affects chemoreceptor-related processes of respiratory and BP regulation. With the HTN progression, cerebrovascular dysregulation occurs depending on the BP level. Moreover, hypocapnia is accompanied by the reduction of intracranial venous tone which can lead to increased intracranial pressure and problems with BP regulation in the brain. The threshold level of cardiovascular CO2-reactivity is normally higher than the threshold level of cerebrovascular CO2-reactivity. The changes in cardiovascular CO2-reactivity occur already in the initial period of HTN. Compared to healthy people, hypertensive patients develop slower BP reaction to hyper/hypocapnia, and hypercapnia induced low BP does not restore to the baseline level that can result from the BP dysregulation.
In general, cerebrovascular CO2-reactivity is decreased in HTN patients. However, the cerebrovascular vasodilator function is preserved better than the vasoconstrictor reserve demonstrating that cerebral vessel remodeling in HTN is characterized by luminal narrowing due to the vascular wall hypertrophy.
BRIEF GOMMUNICATION
Objective. To investigate the effects of necroptosis inhibitors — necrosulfonamide and necrostatin‑1s — on morphofunctional characteristics of the myocardium in the model of prolonged cold preservation of the donor rat heart. Design and methods. The study was performed on 27 Wistar rats. The animals were divided into the following groups: 1) control (n = 7), 2) dimethylsulfoxide (DMSO, n = 6), 3) necrostatin‑1s (n = 8), 4) necrosulfonamide (n = 6). All test compounds were administered intraperitoneally 1 hour before the start of the experiment. Histidine-tryptophan-ketoglutarate (HTK) solution cooled to 4 °C was used as a preservative agent. DMSO was used as a solvent for necrostatin‑1s and necrosulfonamide. During the experiment, left ventricular pressure, heart rate and coronary flow were recorded. At the end of 8‑hour of ischemia and 2‑hour of reperfusion, myocardial infarct size was planimetrically evaluated. Results. Necrostatin-1s and necrosulfonamide show cardioprotective effects, as evidenced by the significantly lower levels of myocardial necrosis in these groups, as well as the best indices of intracardiac hemodynamics during reperfusion. In the groups of necrosulfonamide and necrostatin‑1s, myocardial infarct size was 32,2 ± 9,6 and 29,0 ± 9,2 %, respectively, which is significantly lower than in control groups and DMSO (54,4 ± 6,6 and 59,2 ± 5,6 %, respectively, p < 0,05). During reperfusion in necrosulfonamide and necrostatin‑1s groups, higher values of pulse intraventricular pressure and coronary flow rates were recorded, as well as lower diastolic intraventricular pressure, compared to control group and DMSO (p < 0,05). Conclusions. Necroptosis inhibitors necrostatin‑1s and necrosulfonamide improve morphofunctional characteristics of the myocardium state during prolonged cold preservation of the donor heart.
ISSN 2411-8524 (Online)